126 related articles for article (PubMed ID: 8074807)
1. Potent inactivation of cathepsins S and L by peptidyl (acyloxy)methyl ketones.
Brömme D; Smith RA; Coles PJ; Kirschke H; Storer AC; Krantz A
Biol Chem Hoppe Seyler; 1994 May; 375(5):343-7. PubMed ID: 8074807
[TBL] [Abstract][Full Text] [Related]
2. The affinity-labelling of cathepsin S with peptidyl diazomethyl ketones. Comparison with the inhibition of cathepsin L and calpain.
Shaw E; Mohanty S; Colic A; Stoka V; Turk V
FEBS Lett; 1993 Nov; 334(3):340-2. PubMed ID: 8243643
[TBL] [Abstract][Full Text] [Related]
3. Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L.
Brömme D; Klaus JL; Okamoto K; Rasnick D; Palmer JT
Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):85-9. PubMed ID: 8670136
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of cysteine proteases by (acyloxy)methyl ketones using S'-P' interactions.
Dai Y; Hedstrom L; Abeles RH
Biochemistry; 2000 May; 39(21):6498-502. PubMed ID: 10828965
[TBL] [Abstract][Full Text] [Related]
5. The properties of peptidyl diazoethanes and chloroethanes as protease inactivators.
Wikstrom P; Kirschke H; Stone S; Shaw E
Arch Biochem Biophys; 1989 Apr; 270(1):286-93. PubMed ID: 2930191
[TBL] [Abstract][Full Text] [Related]
6. Peptidyl (acyloxy)methyl ketones and the quiescent affinity label concept: the departing group as a variable structural element in the design of inactivators of cysteine proteinases.
Krantz A; Copp LJ; Coles PJ; Smith RA; Heard SB
Biochemistry; 1991 May; 30(19):4678-87. PubMed ID: 2029515
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium falciparum: inhibitors of lysosomal cysteine proteinases inhibit a trophozoite proteinase and block parasite development.
Rosenthal PJ; McKerrow JH; Rasnick D; Leech JH
Mol Biochem Parasitol; 1989 Jun; 35(2):177-83. PubMed ID: 2671722
[TBL] [Abstract][Full Text] [Related]
8. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.
Barrett AJ; Kembhavi AA; Brown MA; Kirschke H; Knight CG; Tamai M; Hanada K
Biochem J; 1982 Jan; 201(1):189-98. PubMed ID: 7044372
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins.
Turk B; Bieth JG; Björk I; Dolenc I; Turk D; Cimerman N; Kos J; Colic A; Stoka V; Turk V
Biol Chem Hoppe Seyler; 1995 Apr; 376(4):225-30. PubMed ID: 7626231
[TBL] [Abstract][Full Text] [Related]
10. Potent and selective inactivation of cysteine proteinases with N-peptidyl-O-acyl hydroxylamines.
Brömme D; Schierhorn A; Kirschke H; Wiederanders B; Barth A; Fittkau S; Demuth HU
Biochem J; 1989 Nov; 263(3):861-6. PubMed ID: 2574571
[TBL] [Abstract][Full Text] [Related]
11. Comparative behaviour of calpain and cathepsin B toward peptidyl acyloxymethyl ketones, sulphonium methyl ketones and other potential inhibitors of cysteine proteinases.
Pliura DH; Bonaventura BJ; Smith RA; Coles PJ; Krantz A
Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):759-62. PubMed ID: 1471990
[TBL] [Abstract][Full Text] [Related]
12. Novel N-peptidyl-O-acyl hydroxamates: selective inhibitors of cysteine proteinases.
Brömme D; Neumann U; Kirschke H; Demuth HU
Biochim Biophys Acta; 1993 Oct; 1202(2):271-6. PubMed ID: 8399390
[TBL] [Abstract][Full Text] [Related]
13. Species variations amongst lysosomal cysteine proteinases.
Kirschke H; Locnikar P; Turk V
FEBS Lett; 1984 Aug; 174(1):123-7. PubMed ID: 6468652
[TBL] [Abstract][Full Text] [Related]
14. Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis.
Schick C; Pemberton PA; Shi GP; Kamachi Y; Cataltepe S; Bartuski AJ; Gornstein ER; Brömme D; Chapman HA; Silverman GA
Biochemistry; 1998 Apr; 37(15):5258-66. PubMed ID: 9548757
[TBL] [Abstract][Full Text] [Related]
15. Peptide methyl ketones as reversible inhibitors of cysteine proteinases.
Brömme D; Bartels B; Kirschke H; Fittkau S
J Enzyme Inhib; 1989; 3(1):13-21. PubMed ID: 2487320
[TBL] [Abstract][Full Text] [Related]
16. Development of peptidyl alpha-keto-beta-aldehydes as new inhibitors of cathepsin L--comparisons of potency and selectivity profiles with cathepsin B.
Lynas JF; Hawthorne SJ; Walker B
Bioorg Med Chem Lett; 2000 Aug; 10(15):1771-3. PubMed ID: 10937745
[TBL] [Abstract][Full Text] [Related]
17. Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases.
Mason RW; Sol-Church K; Abrahamson M
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):833-8. PubMed ID: 9480898
[TBL] [Abstract][Full Text] [Related]
18. Rat liver thiol proteinases: cathepsin B, cathepsin H and cathepsin L.
Katunuma N; Towatari T; Kominami E; Hashida S; Takio K; Titani K
Acta Biol Med Ger; 1981; 40(10-11):1419-25. PubMed ID: 6177136
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of calpain by peptidyl fluoromethyl ketones.
Angliker H; Anagli J; Shaw E
J Med Chem; 1992 Jan; 35(2):216-20. PubMed ID: 1732539
[TBL] [Abstract][Full Text] [Related]
20. Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases.
Lalmanach G; Serveau C; Brillard-Bourdet M; Chagas JR; Mayer R; Juliano L; Gauthier F
J Protein Chem; 1995 Nov; 14(8):645-53. PubMed ID: 8747425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
